Blood Screening - Global Market Outlook (2017-2023)

Wednesday, October 4, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Oct. 3, 2017 /PRNewswire/ -- According to Stratistics MRC, the Global Blood Screening market is expected to grow from $1.84 billion in 2016 to reach $3.97 billion by 2023 with a CAGR of 11.6%.

Read the full report: incidence of infectious diseases, rise in consciousness of donating blood, and increase in health care awareness are some of the factors boosting the market growth. In addition,
technological advancements in blood screening techniques, increasing investments in research & development are some of the other factors fuelling the market growth during the forecast period. However, threat from substitute techniques, initial investment costs are some of the restraints limiting the market growth. Blood Screening tests are the foundation of a successful health care system, providing critical information that health care provider and patients need to make the right medical decisions. Blood screening often provide objective, quantitative measurements that inform every stage of care—prevention, detection, diagnosis, treatment, and successful management of health conditions. North America accounted for the largest share in global blood screening market followed by Europe. Growth of the region is attributed to existence of major companies and developed healthcare infrastructure. Asia Pacific is expected to witness huge growth due to developing economies, raising health care expenditure, and increasing demand for blood screening in emerging countries such as China, Japan and India. Some of the key players in global blood screening market include Abbott Laboratories, Alere Inc., Apex Biotechnology Corp., Beckman Coulter (A Subsidiary of Danaher Corporation), Becton, Dickinson and Company, Biomérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche, Grifols, Hemosense Inc., Luminex Corp., Nova Biomedical Corp., Ortho Clinical Diagnostics, Inc., Roche Diagnostics, Siemens Healthineers (A Subsidiary of Siemens AG), Thermo Fisher Scientific, Inc., and Trinity Biotech. Technologies Covered: • Next-generation Sequencing (NGS) • Rapid Tests • Western Blot Assay • Enzyme-Linked Immunosorbent Assay (ELISA) • Nucleic Acid Test (NAT) Product & Service Types Covered: • Software and Services • Instruments • Reagents & Kits Applications Covered: • Diabetes Blood Testing • Cardiovascular Disease Blood Testing • Cancer Blood Testing • Blood Disorder Blood Testing • Autoimmune Disease And Food Allergy Testing • Pregnancy Blood Testing • Liver Disorder Blood Testing • Kidney Disorder Blood Testing • Home-Monitoring Blood Testing • Fertility Blood Testing End Users Covered: • Blood Banks • Hospitals Regions Covered:North America o US o Canada o MexicoEurope o Germany o UK o Italy o France o Spain o Rest of EuropeAsia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia PacificSouth America o Argentina o Brazil o Chile o Rest of South AmericaMiddle East & Africa o Saudi Arabia o UAE o Qatar o South Africa o Rest of Middle East & Africa What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancementsRead the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001


View original content:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store